Our mission is to provide Parkinson's disease patients with next-generation diagnostic brain imaging that’s quick, convenient, and unintimidating.

It’s a mission that reflects the personal experiences of the LikeMinds team.

We’ve seen the devastating impact of degenerative brain diseases on people we care about.

We’re determined to make those diseases a thing of the past.

To accomplish this, we’ve partnered with the global leaders in brain imaging at GE HealthCare to bring our groundbreaking high-speed brain-imaging tracer, Altropane, to market.

By reducing the duration of brain-imaging procedures for Parkinson’s from up to 7 hours to as little as 45 minutes, Altropane promises to be a game changer for doctors, patients, imaging centers, and companies focused on degenerative brain diseases.

And once early and pre-symptomatic detection technologies become available and can be used in coordination with Altropane, its diagnostic impact is likely to become even greater.